Regression modeling of competing risk using R: an in depth guide for clinicians
- PMID: 20062101
- DOI: 10.1038/bmt.2009.359
Regression modeling of competing risk using R: an in depth guide for clinicians
Abstract
We describe how to conduct a regression analysis for competing risks data. The use of an add-on package for the R statistical software is described, which allows for the estimation of the semiparametric proportional hazards model for the subdistribution of a competing risk analysis as proposed by Fine and Gray. J Am Stat Assoc 1999; 94: 496-509.
Similar articles
-
Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring.Biometrics. 2011 Mar;67(1):39-49. doi: 10.1111/j.1541-0420.2010.01420.x. Biometrics. 2011. PMID: 20377575
-
Pseudo-observations in survival analysis.Stat Methods Med Res. 2010 Feb;19(1):71-99. doi: 10.1177/0962280209105020. Epub 2009 Aug 4. Stat Methods Med Res. 2010. PMID: 19654170 Review.
-
Estimating and testing for center effects in competing risks.Stat Med. 2011 Jun 15;30(13):1608-17. doi: 10.1002/sim.4132. Epub 2011 Feb 22. Stat Med. 2011. PMID: 21341296
-
Reduced rank proportional hazards model for competing risks.Biostatistics. 2005 Jul;6(3):465-78. doi: 10.1093/biostatistics/kxi022. Epub 2005 Apr 14. Biostatistics. 2005. PMID: 15831577
-
Allogeneic hematopoietic stem cell transplantation for adult acute lymphoblastic leukemia.Cancer Treat Res. 2009;144:441-54. doi: 10.1007/978-0-387-78580-6_18. Cancer Treat Res. 2009. PMID: 19779879 Review. No abstract available.
Cited by
-
Nomogram Predicts the Role of Contralateral Prophylactic Mastectomy in Male Patients With Unilateral Breast Cancer Based on SEER Database: A Competing Risk Analysis.Front Oncol. 2021 Apr 29;11:587797. doi: 10.3389/fonc.2021.587797. eCollection 2021. Front Oncol. 2021. PMID: 33996535 Free PMC article.
-
Appropriate pre-transplant strategy for patients with myelodysplastic syndromes receiving allogeneic haematopoietic stem cell transplantation after myeloablative conditioning.Front Immunol. 2023 Feb 28;14:1146619. doi: 10.3389/fimmu.2023.1146619. eCollection 2023. Front Immunol. 2023. PMID: 36926344 Free PMC article.
-
Establishment of a Competing Risk Nomogram in Patients with Pulmonary Sarcomatoid Carcinoma.Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338211068960. doi: 10.1177/15330338211068960. Technol Cancer Res Treat. 2022. PMID: 35179409 Free PMC article.
-
Survival of patients with resected primary colorectal mucinous adenocarcinoma: A competing risk nomogram analysis.Oncol Lett. 2019 Dec;18(6):6594-6604. doi: 10.3892/ol.2019.11024. Epub 2019 Oct 30. Oncol Lett. 2019. PMID: 31807175 Free PMC article.
-
The Risk of Heart Disease-Related Death Among Anaplastic Astrocytoma Patients After Chemotherapy: A SEER Population-Based Analysis.Front Oncol. 2022 Jun 20;12:870843. doi: 10.3389/fonc.2022.870843. eCollection 2022. Front Oncol. 2022. PMID: 35795052 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical